Dimensional Fund Advisors LP Prothena Corp Public LTD CO Transaction History

Dimensional Fund Advisors LP

  • $418 Billion
  • Q2 2025

A detailed history of Dimensional Fund Advisors LP transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 962,339 shares of PRTA stock, worth $7.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
962,339
Previous 863,148 11.49%
Holding current value
$7.26 Million
Previous $10.7 Million 45.33%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025
BUY
$4.58 - $12.14 $454,294 - $1.2 Million
99,191 Added 11.49%
962,339 $5.84 Million
Q1 2025

May 13, 2025
SELL
$12.38 - $16.04 $20,860 - $27,027
-1,685 Reduced 0.19%
863,148 $10.7 Million
Q4 2024

Feb 13, 2025
BUY
$11.95 - $18.35 $128,856 - $197,868
10,783 Added 1.26%
864,833 $12 Million
Q3 2024

Nov 07, 2024
SELL
$16.73 - $24.79 $126,043 - $186,767
-7,534 Reduced 0.87%
854,050 $14.3 Million
Q2 2024

Aug 09, 2024
SELL
$19.54 - $26.15 $24,385 - $32,635
-1,248 Reduced 0.14%
861,584 $17.8 Million
Q1 2024

May 10, 2024
SELL
$24.75 - $40.66 $118,874 - $195,289
-4,803 Reduced 0.55%
862,832 $21.4 Million
Q4 2023

Feb 07, 2024
SELL
$32.31 - $52.32 $7.6 Million - $12.3 Million
-235,227 Reduced 21.33%
867,635 $31.5 Million
Q3 2023

Nov 09, 2023
SELL
$47.3 - $70.6 $2.24 Million - $3.34 Million
-47,346 Reduced 4.12%
1,102,862 $53.2 Million
Q2 2023

Aug 09, 2023
SELL
$48.26 - $78.59 $3.98 Million - $6.48 Million
-82,427 Reduced 6.69%
1,150,208 $78.5 Million
Q1 2023

May 12, 2023
SELL
$46.97 - $58.27 $4.13 Million - $5.12 Million
-87,866 Reduced 6.65%
1,232,635 $59.7 Million
Q4 2022

Feb 09, 2023
SELL
$52.05 - $65.0 $8.51 Million - $10.6 Million
-163,404 Reduced 11.01%
1,320,501 $79.6 Million
Q3 2022

Nov 10, 2022
SELL
$25.16 - $60.63 $2.08 Million - $5.02 Million
-82,848 Reduced 5.29%
1,483,905 $90 Million
Q2 2022

Aug 12, 2022
BUY
$22.73 - $39.98 $1.4 Million - $2.46 Million
61,597 Added 4.09%
1,566,753 $42.5 Million
Q1 2022

May 13, 2022
BUY
$30.27 - $49.22 $200,357 - $325,787
6,619 Added 0.44%
1,505,156 $55 Million
Q4 2021

Feb 09, 2022
SELL
$42.11 - $73.26 $3.42 Million - $5.94 Million
-81,111 Reduced 5.13%
1,498,537 $74 Million
Q3 2021

Nov 12, 2021
SELL
$48.2 - $78.89 $275,366 - $450,698
-5,713 Reduced 0.36%
1,579,648 $113 Million
Q2 2021

Aug 12, 2021
BUY
$21.63 - $57.65 $135,382 - $360,831
6,259 Added 0.4%
1,585,361 $81.5 Million
Q1 2021

May 14, 2021
SELL
$11.0 - $28.24 $1.75 Million - $4.49 Million
-158,867 Reduced 9.14%
1,579,102 $39.8 Million
Q4 2020

Feb 25, 2021
BUY
$10.12 - $13.94 $17.6 Million - $24.2 Million
1,737,969 New
1,737,969 $20.9 Million

Others Institutions Holding PRTA

# of Institutions
212
Shares Held
33.5M
Call Options Held
848K
Put Options Held
648K
View Full List

About PROTHENA CORP PUBLIC LTD CO

PRTA Quotes by TradingView
  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $354M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email